Treatment of the patient with diabetes mellitus and risk of nephropathy - What do we know, and what do we need to learn?

[1] Amer Diabet Assoc, 2002, DIABETES CARE, V25, P213

[2] [Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI [10.1001/archinte.1997.00440420033005, DOI 10.1001/ARCHINTE.1997.00440420033005]

[3] Baines LA, 2001, DIABETES, V50, P843

[4] Photo-oxidative degradation in polyisoprene: surface characterization and analysis by atomic force microscopy [J]. POLYMER INTERNATIONAL, 2002, 51 (01) : 12 - 20

[5] Bojestig M., 1997, Diabetologia, V40, pA544

[6] Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) : 861 - 869

[7] Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria [J]. LANCET, 1997, 349 (9068) : 1787 - 1792

[8] Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data [J]. ANNALS OF INTERNAL MEDICINE, 2001, 134 (05) : 370 - 379

[9] Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure [J]. DIABETES CARE, 1998, 21 (01) : 104 - 110

[10] DOYLE AE, 1991, BRIT MED J, V302, P210

[1] Amer Diabet Assoc, 2002, DIABETES CARE, V25, P213

[2] [Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI [10.1001/archinte.1997.00440420033005, DOI 10.1001/ARCHINTE.1997.00440420033005]

[3] Baines LA, 2001, DIABETES, V50, P843

[4] Photo-oxidative degradation in polyisoprene: surface characterization and analysis by atomic force microscopy [J]. POLYMER INTERNATIONAL, 2002, 51 (01) : 12 - 20

[5] Bojestig M., 1997, Diabetologia, V40, pA544

[6] Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) : 861 - 869

[7] Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria [J]. LANCET, 1997, 349 (9068) : 1787 - 1792

[8] Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data [J]. ANNALS OF INTERNAL MEDICINE, 2001, 134 (05) : 370 - 379

[9] Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure [J]. DIABETES CARE, 1998, 21 (01) : 104 - 110

[10] DOYLE AE, 1991, BRIT MED J, V302, P210